Company genedrive plc

Equities

EHP

GB00B1VKB244

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Chiffre d''affaires - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - London S.E. Other stock markets 11:35:19 2024-04-26 am EDT			5-day change	1st Jan Change
5.375 ^GBX	-4.44%		-8.51%	-33.85%

Apr. 24	Genedrive enters clinical trial deal in US for MT-RNR1 US approval	AN
Apr. 03	FTSE 100 up thanks to US economic data	AN

genedrive plc is a United Kingdom-based patient molecular diagnostics company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company offers products, including Genedrive MT-RNR1 ID Kit and Genedrive COV19-ID Kit. Genedrive MT-RNR1 ID Kit is a rapid genetic test in an emergency neonatal care setting. It has developed tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of hepatitis c virus (HCV), infection prior to drug administration, pathogen detection of biological military threats, and a point-of-care for COVID-19 detection system for us in areas such as healthcare, workplace screening, travel requirements, or confirmation of antigen tests.

Number of employees: 43

GBP in Million	2022	Weight	2023	Weight	Delta
Diagnostics 100.0 %	0	100.0 %	0	100.0 %	+12.24%

GBP in Million	Weight	Weight	Delta
United Kingdom 63.6 %	75.5 %	63.6 %	-5.41%
Europe 29.1 %	20.4 %	29.1 %	+60.00%
United States 7.3 %	4.1 %	7.3 %	+100.00%

Managers	Title	Age	Since
James Cheek CEO	Chief Executive Officer	57	23-09-10
Russell Shaw DFI	Director of Finance/CFO	45	22-04-06
Ian Gilham CHM	Chairman	64	14-11-23
Gino Miele CTO	Chief Tech/Sci/R&D Officer	54	15-06-30

Members of the board	Title	Age	Since
Ian Gilham CHM	Chairman	64	14-11-23
Chris Yates BRD	Director/Board Member	50	18-08-21
Thomas Lindsay BRD	Director/Board Member	66	18-04-08
Russell Shaw DFI	Director of Finance/CFO	45	22-04-06
James Cheek CEO	Chief Executive Officer	57	23-09-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	143,141,481	68,602,023 ( 47.93 %)	0	47.93 %

Name	Equities	%	Valuation
Hargreaves Lansdown Asset Management Ltd. 3.956 %	5,477,000	3.956 %	233 485 p
IG Markets Ltd. 1.975 %	2,735,000	1.975 %	116 593 p
Rathbones Investment Management Ltd. 1.694 %	2,345,000	1.694 %	99 967 p
HSBC Global Asset Management (UK) Ltd. 1.593 %	2,205,000	1.593 %	93 999 p
Walker Crips Investment Management Ltd. 1.369 %	1,895,000	1.369 %	80 784 p
Unicorn Asset Management Ltd. 0.8340 %	1,154,697	0.8340 %	49 225 p
Octopus Investments Ltd. 0.4495 %	622,309	0.4495 %	26 529 p
Peel Hunt LLP 0.4456 %	617,000	0.4456 %	26 303 p
Ian Gilham 0.4437 %	614,295	0.4437 %	26 187 p
Evelyn Partners Investment Management Services Ltd. 0.3611 %	500,000	0.3611 %	21 315 p

Genedrive Plc

48 Grafton Street

M13 9XX, Manchester

+44 16 1989 0245

http://www.genedriveplc.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
GENEDRIVE PLC	-33.85%	9.58M
SARTORIUS AG	-12.91%	19.08B
QUIDELORTHO CORPORATION	-46.21%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.15%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.12%	1.61B
BIOTAGE AB	+23.78%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.69%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.89%	905M
REVENIO GROUP OYJ	-7.14%	716M
VAREX IMAGING CORPORATION	-18.10%	682M

Medical Diagnostic & Testing Equipment